Skip To Main Content
Rasel Khan Nishan on Muck Rack

Rasel Khan Nishan

As seen in: Preprints.org
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Rasel Khan

Contact Rasel Khan, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

A ceRNA-Based Multi-Omics Analysis Identifies a Prognostic Signature in Lung Adenocarcinoma

|
By Rasel Khan Nishan, Shariful Islam, Abul Kalam Azad
| Preprints.org
Submitted: 10 November 2026 You are already at the latest version Lung adenocarcinoma (LUAD) remains clinically heterogeneous, and competing endogenous RNA (ceRNA) derived prognostic biomarkers require further characterization. This study integrated TCGA-LUAD RNA-seq, miRNA-seq, survival, mutation, and methylation data to generate a ceRNA network and develop a survival-associated signature.
Open in Who Shared Issue with article?

Computational Design and Biophysical Evaluation of VC032: A Multi-Epitope Vaccine Candidate Targeting Four Human-Pathogenic Orthoebolaviruses

|
By Ariful Islam, Abul Kalam Azad, Rasel Khan Nishan
| Preprints.org
Submitted: 10 November 2026 You are already at the latest version Ebola Virus Disease (EVD), caused by four human-pathogenic Orthoebolavirus species (Bundibugyo, Sudan, Taï Forest, and Zaire ebolaviruses), presents severe mortality (40%–90%). Licensed vaccines confer protection exclusively against Zaire ebolavirus, leaving persistent vulnerabilities against heterologous species due to 30%–40% envelope glycoprotein divergence.
Open in Who Shared Issue with article?
See all 2 articles